Literature DB >> 26767627

Down-regulation of GRα expression and inhibition of its nuclear translocation by hypoxia.

Pei Zhang1, Lei Fang1, HuiMei Wu1, Peishan Ding1, QiYing Shen1, Rongyu Liu1.   

Abstract

AIMS: Glucocorticoids are the most effective anti-inflammatory agent in treating pulmonary diseases typically accompanied by hypoxia. Our previous study has demonstrated that glucocorticoid receptor α (GRα) expression is reduced in hypoxia but the underlying mechanism remains elusive. In this study we aim to identify the signaling pathway involved in hypoxia-induced down-regulation of GRα, and whether hypoxia affects nuclear translocation of GRα. MAIN
METHODS: Female C57BL/6 mice were sensitized with saline or ovalbumin (OVA) as the in vivo model. Mice were divided into control and OVA groups, and their lung histology and the expression of hypoxia inducible factor (HIF-1) and GRα were examined. A549 cells were exposed to chemical hypoxia as the in vitro model, where mitogen-activated protein kinases (MAPKs) were inhibited specifically by SB203580. Next, under normal or hypoxic conditions, the expression of GRα, MAPKs and HIF-1 signal protein were determined by Western blot analysis, and GRα translocation were observed through live-cell imaging. KEY
FINDINGS: In OVA challenged mice the expression of GRα was down-regulated whereas HIF-1 was up-regulated. Hypoxia caused a time-dependent decrease of GRα expression, and activated multiple signaling pathways including MAPKs and HIF-1. Moreover, GRα expression increased with MAPK inhibition. Interestingly, only MAPK inhibitor SB203580, but not JNK inhibitor SP600125 or ERK inhibitor U0126 improved the expression of GRα under hypoxic condition. GRα nuclear translocation was also significantly inhibited by hypoxia. SIGNIFICANCE: Hypoxia down-regulated the expression of GRα through p38 signaling pathway, as well as inhibited GRα nuclear translocation significantly.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glucocorticoids receptor; Hypoxia; Nuclear translocation; p38

Mesh:

Substances:

Year:  2016        PMID: 26767627     DOI: 10.1016/j.lfs.2015.12.059

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Prenatal metyrapone treatment modulates neonatal cerebrovascular structure, function, and vulnerability to mild hypoxic-ischemic injury.

Authors:  P Naomi Franco; Lara M Durrant; Desirelys Carreon; Elizabeth Haddad; Adam Vergara; Catherine Cascavita; Andre Obenaus; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

2.  Understanding mechanisms of oocyte development by follicular fluid lipidomics.

Authors:  Daniela Antunes Montani; Daniela Paes de Almeida Ferreira Braga; Edson Borges; Mariana Camargo; Fernanda Bertuccez Cordeiro; Eduardo Jorge Pilau; Fábio Cesar Gozzo; Renato Fraietta; Edson Guimarães Lo Turco
Journal:  J Assist Reprod Genet       Date:  2019-04-23       Impact factor: 3.412

3.  Active Ingredients of Epimedii Folium and Ligustri Lucidi Fructus Balanced GR/HSP90 to Improve the Sensitivity of Asthmatic Rats to Budesonide.

Authors:  Xiufeng Tang; Xiaoxi Li; Honglei Nian; Yan Yang; Yuheng Chen; Xiujuan Wang; Liping Xu; Xinwei Yang; Renhui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-11       Impact factor: 2.629

Review 4.  Bidirectional Crosstalk Between Hypoxia Inducible Factors and Glucocorticoid Signalling in Health and Disease.

Authors:  Tineke Vanderhaeghen; Rudi Beyaert; Claude Libert
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

5.  Bidirectional crosstalk between Hypoxia-Inducible Factor and glucocorticoid signalling in zebrafish larvae.

Authors:  Davide Marchi; Kirankumar Santhakumar; Eleanor Markham; Nan Li; Karl-Heinz Storbeck; Nils Krone; Vincent T Cunliffe; Fredericus J M van Eeden
Journal:  PLoS Genet       Date:  2020-05-07       Impact factor: 5.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.